Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Pulmonary Hypertension

  Free Subscription

Articles published in Rev Mal Respir

Retrieve available abstracts of 18 articles:
HTML format

Single Articles

    December 2020
  1. TREFFEL G, Guillaumot A, Gomez E, Eyries M, et al
    [Familial pulmonary veno-occlusive disease with a composite biallelic heterozygous EIF2AK4 mutation].
    Rev Mal Respir. 2020;37:823-828.
    PubMed     Abstract available

    July 2020
  2. ELHAGE S, Degano B, Soumagne T
    [Management of pulmonary arteriovenous malformation with pulmonary hypertension].
    Rev Mal Respir. 2020 Jul 13. pii: S0761-8425(20)30212.
    PubMed     Abstract available

    March 2020
  3. CARDOUAT G, Guibert C, Freund-Michel V
    [The expression and role of nerve growth factor (NGF) in pulmonary hypertension].
    Rev Mal Respir. 2020 Mar 6. pii: S0761-8425(20)30032.
    PubMed     Abstract available

  4. VALENTIN S, Zysman M, Guillaumot A, Gomez E, et al
    [The impact of exposure to cigarette smoke on the haemodynamic response during exercise of patients under specific treatment for pulmonary arterial hypertension].
    Rev Mal Respir. 2020;37:222-234.
    PubMed     Abstract available

  5. AUBRY A, Paternot A, Vieillard-Baron A
    [Cor pulmonale].
    Rev Mal Respir. 2020;37:257-266.
    PubMed     Abstract available

    February 2020
  6. BOUCLY A, Savale L, Vuillard C, Turpin M, et al
    [Management of right ventricular failure in pulmonary vascular diseases].
    Rev Mal Respir. 2020;37:171-179.
    PubMed     Abstract available

    October 2019
  7. PARENT F, Sanchez O
    [When and how to investigate chronic thrombo-embolic pulmonary hypertension after a pulmonary embolism?]
    Rev Mal Respir. 2019 Oct 11. pii: S0761-8425(19)30214.

    April 2019
  8. BORDENAVE J, Tu L, Savale L, Huertas A, et al
    [New insights in the pathogenesis of pulmonary arterial hypertension].
    Rev Mal Respir. 2019;36:433-437.
    PubMed     Abstract available

  9. FALQUE L, Gheerbrant H, Saint-Raymond C, Quetant S, et al
    [Selection of lung transplant candidates in France in 2019].
    Rev Mal Respir. 2019;36:508-518.
    PubMed     Abstract available

    December 2018
  10. CHEMLA D, Berthelot E, Assayag P, Attal P, et al
    [Pathophysiology of right ventricular hemodynamics].
    Rev Mal Respir. 2018;35:1050-1062.
    PubMed     Abstract available

    November 2018
  11. RIGAUD P, Traclet J, Cottin V
    [Etiological diagnosis of pulmonary hypertension: A cause of difficult diagnosis].
    Rev Mal Respir. 2018 Nov 22. pii: S0761-8425(18)30999.
    PubMed     Abstract available

    September 2018
  12. CHAOUAT A, Cherifi A, Sitbon O, Girerd N, et al
    [Evaluation of cardiac MRI in the follow up assessment of patients with pulmonary arterial hypertension].
    Rev Mal Respir. 2018;35:749-758.
    PubMed     Abstract available

    April 2018
  13. NAEIJE R
    [Altitude and the right heart].
    Rev Mal Respir. 2018;35:441-451.
    PubMed     Abstract available

    March 2018
  14. PALOT A, Ferrandez C, Alagha K, Ilstad-Minnihan A, et al
    [Neurofibromatosis as a cause of breathlessness].
    Rev Mal Respir. 2018;35:338-341.
    PubMed     Abstract available

  15. KOSZUTSKI M, Faure M, Guillaumot A, Gomez E, et al
    [Tunnelled central venous catheter infection during treatment with epoprostenol].
    Rev Mal Respir. 2018;35:324-327.
    PubMed     Abstract available

    March 2017
  16. BRAVOS E, Bayle-Bleuez S, Wahart A, Lacheze R, et al
    [A not so poorly-defined opacity].
    Rev Mal Respir. 2017;34:249-252.
    PubMed     Abstract available

    June 2016
  17. REVIRON-RABEC L, Girerd B, Seferian A, Campbell K, et al
    Pulmonary complications of type 1 neurofibromatosis.
    Rev Mal Respir. 2016;33:460-73.
    PubMed     Abstract available

    May 2016
  18. GOYARD C, Sanchez O, Mourin G, Mussot S, et al
    [Angiosarcoma mimicking recurrent pulmonary embolism].
    Rev Mal Respir. 2016;33:377-82.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.